Supplementary Figures S1-S6 from Acquired On-Target Alterations Drive Clinical Resistance to p53-Y220C Reactivators
Authors:
- Ferran Fece de la CruzFCFerran Fece de la Cruz
- Andreas VarkarisAVAndreas Varkaris
- Parasvi S. PatelPPParasvi S. Patel
- Elijah W. KushnerEKElijah W. Kushner
- Alvin A. Morales-GironAMAlvin A. Morales-Giron
- Sangmi Sandra LeeSLSangmi Sandra Lee
- Ankit SinghASAnkit Singh
- Clara T. KimCKClara T. Kim
- Bryanna L. NordenBNBryanna L. Norden
- Sara EhnstromSESara Ehnstrom
- Jakob M. RiedlJRJakob M. Riedl
- Jacquelyn M. CurtisJCJacquelyn M. Curtis
Open Access
- 1 April 2026
- other
- Published by American Association for Cancer Research (AACR)